Output details
15 - General Engineering
University of Glasgow
Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells
The paper is the first description of microfluidic arrays of single, patient-derived cells to explore chronic myeloid leukaemia (CML), a hematopoietic stem cell disorder. Dynamic, on-chip, three-colour cell viability assays revealed information on the heterogeneity of response of cells to the first-line drug, dasatinib. This work was a major output of the IRC in Proteomic Technologies (BB/C511572/1) and has since informed clinical practice on the treatment of CML regarding the efficacy of the drug within the Leukaemia and Lymphoma Research and Therapy Acceleration Programme at the Beatson West of Scotland Cancer Centre (Contact: Dr. Copland, Mhairi.Copland@glasgow.ac.uk).




